• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Belantamab Mafotodin-Induced Epithelial Keratopathy Masquerading Myopic Surgery.

作者信息

Rousseau Antoine, Michot Jean-Marie, Labetoulle Marc

机构信息

Department of Ophthalmology, Bicêtre Hospital, Assistance Publique - Hôpitaux de Paris, Paris-Saclay University, French Reference Center for FAP (NNERF), French reference network for rare ophthalmologic diseases (OPHTARA), Le Kremlin-Bicêtre, France.

Department of Therapeutic Innovation and Early Testing, Gustave Roussy Cancer Center, Hospital, Villejuif, France.

出版信息

Ophthalmology. 2020 Dec;127(12):1626. doi: 10.1016/j.ophtha.2020.07.047.

DOI:10.1016/j.ophtha.2020.07.047
PMID:33222774
Abstract
摘要

相似文献

1
Belantamab Mafotodin-Induced Epithelial Keratopathy Masquerading Myopic Surgery.贝利妥莫单抗诱导的上皮性角膜病变伪装成近视手术。
Ophthalmology. 2020 Dec;127(12):1626. doi: 10.1016/j.ophtha.2020.07.047.
2
The observation during small incision lenticule extraction for myopia with corneal opacity.角膜混浊近视患者小切口透镜切除术的观察
BMC Ophthalmol. 2017 May 25;17(1):80. doi: 10.1186/s12886-017-0474-7.
3
Topography-based screening for previous laser in situ keratomileusis to correct myopia and hyperopia.基于地形图的既往准分子原位角膜磨镶术筛查以矫正近视和远视。
Cornea. 2005 Mar;24(2):167-77. doi: 10.1097/00003226-200503000-00008.
4
Transepithelial Topography-Guided Ablation Assisted by Epithelial Thickness Mapping for Treatment of Regression After Myopic Refractive Surgery.上皮厚度测绘引导经上皮角膜重塑术治疗近视矫正术后回退
J Refract Surg. 2019 Aug 1;35(8):525-533. doi: 10.3928/1081597X-20190730-01.
5
West Indian (Caribbean) punctate keratopathy: clinical and in vivo confocal microscopical findings.西印度（加勒比海）点状角膜病变：临床和活体共聚焦显微镜检查结果。
Cornea. 2011 Nov;30(11):1270-2. doi: 10.1097/ICO.0b013e31821b721c.
6
Corneal in vivo confocal microscopy to detect belantamab mafodotin-induced ocular toxicity early and adjust the dose accordingly: a case report.应用角膜共聚焦显微镜早期检测贝兰他单抗马妥昔单抗诱导的眼部毒性并相应调整剂量：病例报告。
J Hematol Oncol. 2021 Oct 3;14(1):159. doi: 10.1186/s13045-021-01172-5.
7
Adjuvant collagen crosslinking for treatment of epithelial ingrowth after small-incision lenticule extraction.辅助性胶原交联治疗小切口透镜切除术术后上皮内生
Clin Exp Ophthalmol. 2018 Jul;46(5):554-556. doi: 10.1111/ceo.13094. Epub 2017 Nov 29.
8
Longitudinal and Regional Non-uniform Remodeling of Corneal Epithelium After Topography-Guided FS-LASIK.地形引导的飞秒激光原位角膜磨镶术后角膜上皮的纵向和区域非均匀重塑
J Refract Surg. 2019 Feb 1;35(2):88-95. doi: 10.3928/1081597X-20190104-01.
9
Different refractive errors in triplets with retinopathy of prematurity treated with bevacizumab.接受贝伐单抗治疗的早产儿视网膜病变三胞胎的不同屈光不正情况。
J Pediatr Ophthalmol Strabismus. 2012 Aug 7;49 Online:e41-3. doi: 10.3928/01913913-20120731-03.
10
Refractive Surgical Question: March consultation #1.屈光手术问题：3月咨询#1。
J Cataract Refract Surg. 2014 Mar;40(3):501-2. doi: 10.1016/j.jcrs.2014.01.008.

引用本文的文献

1
Characterization of Belantamab Mafodotin-Induced Corneal Changes in Patients With Multiple Myeloma.多发性骨髓瘤患者中贝利司他单抗诱导的角膜变化特征
JAMA Ophthalmol. 2025 May 8. doi: 10.1001/jamaophthalmol.2025.1008.
2
Incidence and Mitigation of Corneal Pseudomicrocysts Induced by Antibody-Drug Conjugates (ADCs).抗体药物偶联物（ADCs）诱导的角膜假性微囊肿的发生率及缓解情况
Curr Ophthalmol Rep. 2024 Jun;12(2):13-22. doi: 10.1007/s40135-024-00322-5. Epub 2024 Mar 24.
3
Adverse events of antibody-drug conjugates on the ocular surface in cancer therapy.
抗体药物偶联物在癌症治疗中对眼表面的不良反应。
Clin Transl Oncol. 2023 Nov;25(11):3086-3100. doi: 10.1007/s12094-023-03261-y. Epub 2023 Jul 15.
4
Dupilumab-Induced, Tralokinumab-Induced, and Belantamab Mafodotin-Induced Adverse Ocular Events-Incidence, Etiology, and Management.度普利尤单抗相关、特利鲁单抗相关和贝林妥欧单抗相关不良眼部事件——发生率、病因和管理。
Cornea. 2023 Apr 1;42(4):507-519. doi: 10.1097/ICO.0000000000003162. Epub 2022 Dec 15.
5
A novel agent for myeloma causing toxic keratopathy, belantamab mafodotin: a case report and literature review.一种导致毒性角膜病变的新型骨髓瘤药物——贝兰他单抗莫福汀：病例报告及文献综述
Arq Bras Oftalmol. 2022 Nov 4;87(4). doi: 10.5935/0004-2749.2021-0358.
6
Refractive Shifts and Changes in Corneal Curvature Associated With Antibody-Drug Conjugates.与抗体药物偶联物相关的屈光变化和角膜曲率变化。
Cornea. 2022 Jun 1;41(6):792-801. doi: 10.1097/ICO.0000000000002934. Epub 2021 Nov 23.
7
Corneal in vivo confocal microscopy to detect belantamab mafodotin-induced ocular toxicity early and adjust the dose accordingly: a case report.应用角膜共聚焦显微镜早期检测贝兰他单抗马妥昔单抗诱导的眼部毒性并相应调整剂量：病例报告。
J Hematol Oncol. 2021 Oct 3;14(1):159. doi: 10.1186/s13045-021-01172-5.
8
Structural changes of corneal epithelium in belantamab-associated superficial keratopathy using anterior segment optical coherence tomography.使用眼前节光学相干断层扫描技术观察贝兰他单抗相关浅层角膜病变中角膜上皮的结构变化。
Am J Ophthalmol Case Rep. 2021 Jun 9;23:101133. doi: 10.1016/j.ajoc.2021.101133. eCollection 2021 Sep.
9
Ocular Toxicity of Belantamab Mafodotin, an Oncological Perspective of Management in Relapsed and Refractory Multiple Myeloma.贝兰他单抗莫福汀的眼部毒性：复发难治性多发性骨髓瘤治疗的肿瘤学视角
Front Oncol. 2021 May 11;11:678634. doi: 10.3389/fonc.2021.678634. eCollection 2021.
10
Ocular Toxicity of Targeted Anticancer Agents.靶向抗癌药物的眼部毒性。
Drugs. 2021 May;81(7):771-823. doi: 10.1007/s40265-021-01507-z. Epub 2021 Mar 31.